Search the collection

7 results for Hartung,+Hans-Peter,+MD

Sort by:

Sort by

Limit results to:

20 per page

7 results for Hartung,+Hans-Peter,+MD

Export to excel

Export record to excel

File type to download

Beta version

Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 1
ArticlesPeer ReviewedFull Text
250 μg or 500 μg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study
Author / Creator:O'Connor, Paul, MD ; Filippi, Massimo, MD ; Arnason, Barry, MD ; Comi, Giancarlo, MD ; Cook, Stuart, MD ; Goodin, Douglas, MD ; Hartung, Hans-Peter, MD ; Jeffery, Douglas, MD ; Kappos, Ludwig, MD ; Boateng, Francis, PhD ; Filippov, Vitali, PhD ; Groth, Maria, MD ; Knappertz, Volker, MD ; Kraus, Christian, MD ; Sandbrink, Rupert, MD ; Pohl, Christoph, MD ; Bogumil, Timon, MD
Publisher:Elsevier Ltd
Journal title:Lancet neurology, 2009-10, Vol.8 (10), p.889-897
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 2
ArticlesPeer ReviewedFull Text
Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial
Author / Creator:Hughes, Richard AC, MD ; Donofrio, Peter, MD ; Bril, Vera, MD ; Dalakas, Marinos C, MD ; Deng, Chunqin, PhD ; Hanna, Kim, MSc ; Hartung, Hans-Peter, MD ; Latov, Norman, MD ; Merkies, Ingemar SJ, MD ; van Doorn, Pieter A, MD
Publisher:England: Elsevier Ltd
Journal title:Lancet neurology, 2008-02, Vol.7 (2), p.136-144
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 3
ArticlesPeer ReviewedFull Text
Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial
Author / Creator:Kappos, Ludwig, MD ; Freedman, Mark S, MD ; Polman, Chris H, MD ; Edan, Gilles, MD ; Hartung, Hans-Peter, MD ; Miller, David H, MD ; Montalbán, Xavier, MD ; Barkhof, Frederik, MD ; Radü, Ernst-Wilhelm, MD ; Metzig, Carola, MD ; Bauer, Lars, MD ; Lanius, Vivian, PhD ; Sandbrink, Rupert, MD ; Pohl, Christoph, MD
Publisher:England: Elsevier Ltd
Journal title:Lancet neurology, 2009-11, Vol.8 (11), p.987-997
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 4
ArticlesPeer ReviewedFull Text
Comparison of fingolimod with interferon beta-1a in relapsing-remitting multiple sclerosis: a randomised extension of the TRANSFORMS study
Author / Creator:Khatri, Bhupendra, Dr ; Barkhof, Frederik, MD ; Comi, Giancarlo, MD ; Hartung, Hans-Peter, MD ; Kappos, Ludwig, MD ; Montalban, Xavier, MD ; Pelletier, Jean, MD ; Stites, Tracy, PhD ; Wu, Stacy, MD ; Holdbrook, Fred, PhD ; Zhang-Auberson, Lixin, MD ; Francis, Gordon, MD ; Cohen, Jeffrey A, MD
Publisher:England: Elsevier Ltd
Journal title:Lancet neurology, 2011-06, Vol.10 (6), p.520-529
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 5
ArticlesPeer ReviewedFull Text
GNbAC1, a Humanized Monoclonal Antibody Against the Envelope Protein of Multiple Sclerosis—Associated Endogenous Retrovirus: A First-in-Humans Randomized Clinical Study
Author / Creator:Curtin, François, MD ; Lang, Alois B., PhD ; Perron, Hervé, PhD ; Laumonier, Marion, MSc ; Vidal, Virginie, MSc ; Porchet, Hervé C., MD ; Hartung, Hans-Peter, MD
Publisher:Bridgewater, NJ: Elsevier Inc
Journal title:Clinical therapeutics, 2012-12, Vol.34 (12), p.2268-2278
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 6
ArticlesPeer ReviewedFull Text
Natalizumab treatment for multiple sclerosis: recommendations for patient selection and monitoring
Author / Creator:Kappos, Ludwig, Prof ; Bates, David, MD ; Hartung, Hans-Peter, MD ; Havrdova, Eva, MD ; Miller, David, MD ; Polman, Chris H, MD ; Ravnborg, Mads, MD ; Hauser, Stephen L, MD ; Rudick, Richard A, MD ; Weiner, Howard L, MD ; O'Connor, Paul W, MD ; King, John, MD ; Radue, Ernst Wilhelm, MD ; Yousry, Tarek, MD ; Major, Eugene O, PhD ; Clifford, David B, MD
Publisher:England: Elsevier Ltd
Journal title:Lancet neurology, 2007-05, Vol.6 (5), p.431-441
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 7
ArticlesPeer ReviewedFull Text
Cost-Effectiveness Analysis of Interferon Beta-1b for the Treatment of Patients With a First Clinical Event Suggestive of Multiple Sclerosis
Author / Creator:Caloyeras, John P., MPhil ; Zhang, Bin, MD, MSc ; Wang, Cheng, MD, PhD ; Eriksson, Marianne, MSc ; Fredrikson, Sten, MD, PhD ; Beckmann, Karola, MSc ; Knappertz, Volker, MD ; Pohl, Christoph, MD ; Hartung, Hans-Peter, MD ; Shah, Dhvani, MS ; Miller, Jeffrey D., MS ; Sandbrink, Rupert, MD ; Lanius, Vivian, PhD ; Gondek, Kathleen, PhD ; Russell, Mason W., MAPE
Publisher:Bridgewater, NJ: EM Inc USA
Journal title:Clinical therapeutics, 2012-05, Vol.34 (5), p.1132-1144
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.

Search the collection

Export record to excel

Export this record

Export record to excel

250 μg or 500 μg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study

Export this record

Export record to excel

Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial

Export this record

Export record to excel

Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial

Export this record

Export record to excel

Comparison of fingolimod with interferon beta-1a in relapsing-remitting multiple sclerosis: a randomised extension of the TRANSFORMS study

Export this record

Export record to excel

GNbAC1, a Humanized Monoclonal Antibody Against the Envelope Protein of Multiple Sclerosis—Associated Endogenous Retrovirus: A First-in-Humans Randomized Clinical Study

Export this record

Export record to excel

Natalizumab treatment for multiple sclerosis: recommendations for patient selection and monitoring

Export this record

Export record to excel

Cost-Effectiveness Analysis of Interferon Beta-1b for the Treatment of Patients With a First Clinical Event Suggestive of Multiple Sclerosis

Refine your search